Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone plus bupivacaine for caudal block in children undergoing inguinal hernia surgery
IRCT20180401039168N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Apr 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexamethasone and bupivacaine in inguinal hernia (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Postoperative pain. Started Apr 2018; status: completed.
02
Drugs
dexamethasonebupivacaine
03
Conditions
inguinal hernia
Beyond the preview
Go deeper on IRCT20180401039168N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180401039168N1.